Emovi Announces Results of Clinical Trial to Manage Knee Osteoarthritis with KneeKGTM
Today, Emovi, Inc. announces positive results from a randomized, controlled trial involving KneeKG™, Emovi’s flagship medical device and the first device that enables healthcare professionals to accurately assess patients’ knees in 3D while the patient is moving and weight-bearing. Read more >>